Ratings by Citi (Yigal Nochomovitz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/27/2023 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2023 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2022 | ProQR Therapeutics N.V. | PRQR | Maintain | Neutral (N/A) |
|
Details | ||
| 12/14/2022 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
49.59 (52.50) |
5.87% | Details | |
| 12/5/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2022 | Rigel Pharmaceuticals | RIGL | Upgrade | Buy (Neutral) |
0.68 (1.70) |
150% | Details | |
| 11/28/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
6.18 (5.87) |
-5.02% | Details | |
| 11/23/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/23/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Arcturus Therapeutics | ARCT | Upgrade | Buy (Neutral) |
21.69 (22.24) |
2.54% | Details | |
| 10/14/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | ProKidney | PROK | New Coverage | Buy (N/A) |
10.25 (10.59) |
3.32% | Details | |
| 9/22/2022 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
2.30 (2.23) |
-3.04% | Details | |
| 9/16/2022 | Opthea Ltd. | OPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2022 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 8/29/2022 | Aerie Pharma | AERI | Downgrade | Neutral (Buy) |
15.10 (15.25) |
0.99% | Details | |
| 8/26/2022 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2022 | Atara Biotherapeutics | ATRA | Downgrade | Sell (Neutral) |
3.64 (5.49) |
50.82% | Details | |
| 7/19/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2022 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2022 | Rigel Pharmaceuticals | RIGL | Downgrade | Neutral (Buy) |
1.76 (0.68) |
-61.36% | Details | |
| 6/1/2022 | Shattuck Labs | STTK | New Coverage | Buy (N/A) |
2.72 (4.23) |
55.51% | Details | |
| 5/20/2022 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 5/20/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2022 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 5/12/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Atara Biotherapeutics | ATRA | Downgrade | Neutral (Buy) |
6.92 (3.64) |
-47.4% | Details | |
| 4/21/2022 | Arcturus Therapeutics | ARCT | Downgrade | Neutral (Buy) |
25.26 (21.69) |
-14.13% | Details | |
| 4/8/2022 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2022 | Imara Inc. | IMRA | Downgrade | Neutral (Buy) |
1.63 (5.05) |
209.82% | Details | |
| 3/16/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | MacroGenics | MGNX | Upgrade | Buy (Neutral) |
9.67 (5.87) |
-39.3% | Details | |
| 2/14/2022 | ProQR Therapeutics N.V. | PRQR | Downgrade | Neutral (Buy) |
5.64 (2.97) |
-47.34% | Details | |
| 12/21/2021 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2021 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2021 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 12/3/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2021 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Caribou Biosciences Inc. | CRBU | Upgrade | Buy (Neutral) |
20.52 (7.39) |
-63.99% | Details | |
| 11/9/2021 | Fate Therapeutics | FATE | Upgrade | Buy (Neutral) |
61.42 (6.74) |
-89.03% | Details | |
| 10/11/2021 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2021 | Harpoon Therapeutics | HARP | Upgrade | Buy (Neutral) |
7.96 (1.05) |
-86.81% | Details | |
| 9/28/2021 | Puma Biotechnology | PBYI | Upgrade | Buy (Neutral) |
6.82 (4.57) |
-32.99% | Details | |
| 9/22/2021 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2021 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2021 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2021 | Caribou Biosciences Inc. | CRBU | New Coverage | Neutral (N/A) |
26.48 (7.39) |
-72.09% | Details | |
| 8/13/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
37.92 (38.22) |
0.79% | Details | |
| 7/23/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Unity Biotechnology Inc | UBX | Upgrade | Buy (Sell) |
4.34 (5.07) |
16.82% | Details | |
| 6/14/2021 | CRISPR Therapeutics | CRSP | Upgrade | Neutral (Sell) |
123.71 (55.33) |
-55.27% | Details | |
| 6/8/2021 | Harpoon Therapeutics | HARP | Downgrade | Neutral (Buy) |
15.27 (7.96) |
-47.87% | Details | |
| 6/7/2021 | Merus N.V. | MRUS | Upgrade | Buy (Neutral) |
20.68 (16.64) |
-19.54% | Details | |
| 6/4/2021 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
154.86 (49.59) |
-67.98% | Details | |
| 5/26/2021 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2021 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
17.69 (26.84) |
51.72% | Details | |
| 5/21/2021 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 5/21/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Imara Inc. | IMRA | New Coverage | Buy (N/A) |
7.46 (5.05) |
-32.31% | Details | |
| 5/11/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | Ultragenyx Pharma | RARE | Upgrade | Buy (Neutral) |
101.85 (45.71) |
-55.12% | Details | |
| 3/25/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2021 | Atara Biotherapeutics | ATRA | Upgrade | Buy (Neutral) |
17.10 (5.49) |
-67.89% | Details | |
| 3/1/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Unity Biotechnology Inc | UBX | Downgrade | Sell (Neutral) |
8.28 (5.07) |
-38.77% | Details | |
| 2/11/2021 | Fate Therapeutics | FATE | Downgrade | Neutral (Buy) |
103.31 (6.74) |
-93.48% | Details | |
| 1/28/2021 | Zymeworks | ZYME | Upgrade | Buy (Neutral) |
44.06 (9.82) |
-77.71% | Details | |
| 1/25/2021 | Zymeworks | ZYME | Downgrade | Neutral (Buy) |
52.16 (9.82) |
-81.17% | Details | |
| 1/15/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2021 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2020 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2020 | Atara Biotherapeutics | ATRA | Downgrade | Neutral (Buy) |
26.23 (17.10) |
-34.81% | Details | |
| 12/8/2020 | Lexicon Pharmaceuticals | LXRX | Upgrade | Buy (Neutral) |
1.58 (2.40) |
51.9% | Details | |
| 12/7/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2020 | Ovid Therapeutics Inc | OVID | Downgrade | Neutral (Buy) |
6.84 (2.43) |
-64.47% | Details | |
| 11/25/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2020 | Arcturus Therapeutics | ARCT | New Coverage | Buy (N/A) |
49.97 (22.24) |
-55.49% | Details | |
| 9/18/2020 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
161.97 (52.50) |
-67.59% | Details | |
| 8/19/2020 | Cellectis | CLLS | Upgrade | Buy (Buy) |
17.22 (2.60) |
-84.9% | Details | |
| 8/18/2020 | Unity Biotechnology Inc | UBX | Downgrade | Neutral (Buy) |
12.43 (5.07) |
-59.21% | Details | |
| 8/17/2020 | Imara Inc. | IMRA | Upgrade | Buy (Neutral) |
20.61 (5.05) |
-75.5% | Details | |
| 8/11/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
26.75 (5.87) |
-78.06% | Details | |
| 7/13/2020 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Imara Inc. | IMRA | Downgrade | Neutral (Buy) |
34.23 (5.05) |
-85.25% | Details | |
| 6/26/2020 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Arvinas Inc. | ARVN | Upgrade | Buy (Neutral) |
44.85 (34.59) |
-22.88% | Details | |
| 5/8/2020 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Portola Pharmaceuticals | PTLA | Downgrade | Neutral (Buy) |
7.76 (18.03) |
132.35% | Details | |
| 4/28/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/23/2020 | Atara Biotherapeutics | ATRA | Upgrade | Buy (Neutral) |
8.00 (5.49) |
-31.38% | Details | |
| 4/6/2020 | Imara Inc. | IMRA | New Coverage | Buy (N/A) |
15.75 (5.05) |
-67.94% | Details | |
| 3/31/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 3/2/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2020 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
7.33 (3.26) |
-55.53% | Details | |
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2020 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2019 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Aerie Pharma | AERI | New Coverage | Buy (N/A) |
21.92 (15.25) |
-30.43% | Details | |
| 12/18/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2019 | Galera Therapeutics | GRTX | New Coverage | Buy (N/A) |
12.53 (2.44) |
-80.53% | Details | |
| 11/19/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 11/8/2019 | Lexicon Pharmaceuticals | LXRX | Downgrade | Neutral (Buy) |
3.88 (2.40) |
-38.14% | Details | |
| 11/7/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2019 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2019 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2019 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2019 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2019 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2019 | NuCana | NCNA | Maintain | Buy () |
|
Details | ||
| 8/21/2019 | Synlogic Inc. | SYBX | Downgrade | Sell (Buy) |
4.83 (0.90) |
-81.37% | Details | |
| 8/12/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Atara Biotherapeutics | ATRA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 7/30/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2019 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2019 | Eiger BioPharma | EIGR | New Coverage | Buy (N/A) |
10.61 (2.09) |
-80.3% | Details | |
| 6/13/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2019 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 6/5/2019 | Arvinas Inc. | ARVN | Downgrade | Neutral (Buy) |
20.05 (44.85) |
123.69% | Details | |
| 6/4/2019 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
89.20 (52.50) |
-41.14% | Details | |
| 6/4/2019 | Atara Biotherapeutics | ATRA | Upgrade | Neutral (Sell) |
22.21 (5.49) |
-75.28% | Details | |
| 5/24/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2019 | Cellectis | CLLS | New Coverage | Neutral (N/A) |
18.34 (2.60) |
-85.82% | Details | |
| 5/24/2019 | Acceleron Pharma | XLRN | New Coverage | Buy (N/A) |
43.25 (178.75) |
313.29% | Details | |
| 5/24/2019 | Arcus Biosciences | RCUS | New Coverage | Buy (N/A) |
9.52 (20.51) |
115.44% | Details | |
| 5/15/2019 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2019 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2019 | Puma Biotechnology | PBYI | Downgrade | Neutral (Buy) |
30.02 (6.82) |
-77.28% | Details | |
| 5/2/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/21/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2019 | Akebia Therapeutics | AKBA | New Coverage | Neutral (N/A) |
8.17 (1.08) |
-86.78% | Details | |
| 3/15/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/15/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2019 | Chimerix | CMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2019 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
72.80 (89.20) |
22.53% | Details | |
| 3/1/2019 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2019 | MacroGenics | MGNX | Upgrade | Buy (Sell) |
11.11 (5.87) |
-47.16% | Details | |
| 2/4/2019 | MacroGenics | MGNX | Downgrade | Sell (Neutral) |
11.73 (11.11) |
-5.29% | Details | |
| 1/24/2019 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2019 | CRISPR Therapeutics | CRSP | Downgrade | Sell (Neutral) |
37.13 (55.33) |
49.02% | Details | |
| 1/18/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
8.97 (6.19) |
-30.99% | Details | |
| 11/27/2018 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2018 | LOXO | Maintain | Buy (N/A) |
|
Details | |||
| 11/16/2018 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2018 | ProQR Therapeutics N.V. | PRQR | New Coverage | Buy (N/A) |
18.67 (2.97) |
-84.09% | Details | |
| 11/9/2018 | Chimerix | CMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2018 | Ultragenyx Pharma | RARE | Upgrade | Neutral (Sell) |
54.34 (45.71) |
-15.88% | Details | |
| 11/7/2018 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2018 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2018 | Ultragenyx Pharma | RARE | Maintain | Sell (N/A) |
|
Details | ||
| 10/22/2018 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
15.56 (20.05) |
28.86% | Details | |
| 9/28/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2018 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2018 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2018 | Rigel Pharmaceuticals | RIGL | New Coverage | Buy (N/A) |
2.80 (1.70) |
-39.29% | Details | |
| 8/24/2018 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2018 | Synlogic Inc. | SYBX | Upgrade | Buy (Neutral) |
7.91 (4.83) |
-38.94% | Details |
